Clinical Roundup Trial suggests that treatment de-escalation in HER2-positive breast cancer needs to be personalized April 26, 2019Vol.45 No.17
Clinical Roundup Genetic testing in women diagnosed with breast cancer decreases cost of care nationwide April 26, 2019Vol.45 No.17
In Brief $15.1M awarded to Rutgers Cancer Institute of New Jersey for redesignation as Comprehensive Cancer Center April 26, 2019Vol.45 No.17
In Brief Inova dedicates Inova Schar Cancer Institute; John Deeken named president April 26, 2019Vol.45 No.17
In Brief Letter urges exempting FDA rules from review by Congress and the president April 26, 2019Vol.45 No.17
Collins: “Not every one of these investigations is going to reveal something bad, but some of them will” April 26, 2019Vol.45 No.17
Conversation with The Cancer Letter NIH’s Lauer: “We have contacted over 55 institutions” April 26, 2019Vol.45 No.17By Paul Goldberg
Conversation with The Cancer Letter Pisters: “Trust is broken when a grant reviewer decides that an idea should be better done elsewhere” April 26, 2019Vol.45 No.17By Paul Goldberg
